The invention relates to compounds of formula (I) to the pharmaceutical compositions comprising same and to the use thereof in the treatment of bacterial fungal viral and parasitic infections or in the treatment of cancer in humans or animals. In formula (I) R1 and R2 are as defined in claim 1. ...

The invention relates to a vaccine composition  made of excreted/secreted proteins from promastigotes and/or amastigotes of Leishmania sp.  for preventing or treating leishmaniases in mammals  preferably in canidae  to a method for preparing said composition  and to the uses thereof. Said composition consists of: ex...

The present invention relates to a compound of formula (I), in which R’ represents a -(CRaRb)n-X-(CRcRd)m-[Y-(CReRf)o]t-NR9R10 group, and X and Y independently represent a -NR11- group, an –O- group or a divalent heterocyclic group comprising at least one nitrogen atom, with 5 or 6 members; as well as the stereoisom...

The present invention relates to a compound of formula (I), in which R’ represents a –(CRaRb)n-X-(CRcRd)m-[Y-(CReRf)o]t-NR9R10 group, and X and Y independently represent a -NR11- group, an –O- group or a divalent heterocyclic group comprising at least one nitrogen atom, with 5 or 6 members; as well as the stereoisom...